clinical trial · NCT00671008
Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
Novo Nordisk A/S·—·completed·n = 400
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2biphasic insulin aspart 30insulin detemir
brief summary
This trial is conducted in Europe. The aim of this observational study is to evaluate the glycaemic control in patients with type 1 or 2 diabetes using NovoMix® 30 or Levemir® under normal clinical practice conditions.
started
Dec 1, 2007
primary completion
Sep 1, 2008
completion
Sep 1, 2008
last updated
Jan 2, 2024
official title
Efficacy of Glycaemic Control of Biphasic Insulin Aspart (NovoMix® 30) or Insulin Detemir (Levemir®) in Patients With Type 1 or 2 Diabetes Mellitus
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol